Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

FOXN1 gene variants cause low T cells and immune issues from birth.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Special gels help heal diabetic foot sores and reduce the risk of amputation or death.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Dengue virus can infect human hair follicle cells and may cause hair loss.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.